Can a 15-Day antiviral course ease long COVID?
NCT ID NCT05576662
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 28 times
Summary
This study tested whether taking Paxlovid for 15 days reduces severe Long COVID symptoms like fatigue, brain fog, and shortness of breath. 168 adults with persistent symptoms after a COVID-19 infection took either the drug or a placebo. The goal was to see if the treatment improved symptom severity at 10 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.